Joshua B. Pittell
Lawyers
Advises public and private companies and private equity sponsors on a broad range of M&A transactions and general corporate matters.
Josh advises public and private companies on a broad range of mergers and acquisitions, investments, joint ventures, divestitures, carve-outs and other corporate matters. He also advises private equity firms and their portfolio companies on a range of transactions, including acquisitions and dispositions of investments, leveraged buyouts and minority investments.
Experience
Recent Work
- FMC $400 million strategic investment from Tessenderlo Group
- Roche acquisition of SAGA Diagnostics
- Strategic Value Partners acquisition of majority stake in New Frontera
- Integer Holdings cooperation agreement with Irenic Capital Management
- Banco Santander $12.2 billion acquisition of Webster Bank
- GrowthCurve Capital acquisition of PlanHub
- J.F. Lehman credit continuation fund
- S&P Global and CME Group $3.1 billion sale of OSTTRA to KKR
- Sun Pharmaceutical enters into merger agreement with Taro Pharmaceutical
- MSCI $697 million acquisition of Burgiss Group
- Ocado Group acquisition of 6 River Systems
- European Biotech Acquisition $220 million combination with Oculis
- European Biotech Acquisition $200 million combination with Oculis
- Freeman Spogli investment in EverVet
- VersaBank acquisition of Stearns Bank Holdingford
- Cerity Partners recapitalization led by Genstar Capital
Education
J.D., University of Pennsylvania Carey Law School
- cum laude
- Senior Editor, University of Pennsylvania Law Review
B.S., Economics and Sports Management, University of Florida
- summa cum laude
Qualifications and admissions
- State of New York